# BioCina

Type: Company

Source: Biotech Intelligence Brief — https://getbiobrief.com/entity/biocina
Canonical HTML page: https://getbiobrief.com/entity/biocina

## Recent coverage (1 stories)

### BioCina Scales Manufacturing for Patry’s Novel Delirium Injectable Therapeutic
2026-03-17 03:33:06 · Sentiment: Positive · Impact: 6/10 · Sources: 2

BioCina has initiated a comprehensive manufacturing program for Patry, a proprietary injectable therapeutic designed to alleviate delirium. This partnership marks a critical transition from clinical development to scalable production, leveraging BioCina's specialized microbial fermentation capabilities.
Full story: https://getbiobrief.com/story/biocina-patry-delirium-manufacturing-program

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getbiobrief.com/guides/methodology for the full editorial methodology.